| 1 | Cystadenocarcinoma | 38.4% |
| 2 | Mucoepidermoid Carcinoma | 38.4% |
| 3 | Basal cell carcinoma | 36.1% |
| 4 | Carcinoma, Papillary | 36.1% |
| 5 | Squamous cell carcinoma | 36.1% |
| 6 | Carcinoma, Basal Cell | 36.1% |
| 7 | Breast Neoplasms, Male | 34.4% |
| 8 | Triple Negative Breast Neoplasms | 34.4% |
| 9 | Neoplasms, Neuroepithelial | 32.3% |
| 10 | Gliomatosis cerebri | 32.3% |
| 11 | Carcinoma, Ehrlich Tumor | 30.1% |
| 12 | Carcinoma, Lewis Lung | 30.1% |
| 13 | Cystadenoma | 29.6% |
| 14 | Mesothelioma | 29.6% |
| 15 | Carcinoid Tumor | 29.4% |
| 16 | Adenoid Cystic Carcinoma | 28.4% |
| 17 | Adenocarcinoma, Clear Cell | 28.4% |
| 18 | Cholangiocarcinoma | 28.4% |
| 19 | Adenoma | 27.7% |
| 20 | Choriocarcinoma | 27.1% |
| 21 | Carcinoma, Pancreatic Ductal | 26.9% |
| 22 | Bowen's Disease | 25.7% |
| 23 | Carcinoma in Situ | 25.6% |
| 24 | Carcinoma, Transitional Cell | 25.6% |
| 25 | Carcinoma, Large Cell | 25.6% |
| 26 | Carcinoma, Small Cell | 25.6% |
| 27 | Acanthoma | 24.4% |
| 28 | Skin Neoplasms | 23.7% |
| 29 | Medulloblastoma | 23.3% |
| 30 | Malignant Carcinoid Syndrome | 23.2% |
| 31 | leukemia | 22.8% |
| 32 | Neoplasms, Germ Cell and Embryonal | 22.8% |
| 33 | Germ Cell Cancer | 22.8% |
| 34 | Neuroectodermal Tumors | 22.3% |
| 35 | Klatskin Tumor | 22.1% |
| 36 | Adenoma, Acidophil | 21.8% |
| 37 | Ganglioneuroma | 21.8% |
| 38 | Glioma | 21.8% |
| 39 | Malignant Glioma | 21.8% |
| 40 | Meningioma | 20.7% |
| 41 | Breast Cyst | 20.1% |
| 42 | Adrenocortical carcinoma | 19.3% |
| 43 | Adenofibroma | 19.2% |
| 44 | Fibroadenoma | 19.2% |
| 45 | Histiocytic Disorders, Malignant | 19% |
| 46 | melanoma | 18.7% |
| 47 | Hamartoma | 18.6% |
| 48 | Neoplasms, Hormone-Dependent | 18.6% |
| 49 | Neoplasms, Multiple Primary | 18.6% |
| 50 | Paraneoplastic Syndromes | 18.6% |
| 51 | Precancerous Conditions | 18.6% |
| 52 | Neoplasms, Second Primary | 18.6% |
| 53 | Carcinosarcoma | 18.4% |
| 54 | Hemangiosarcoma | 18.4% |
| 55 | lymphangiosarcoma | 18.4% |
| 56 | Carcinoma 256, Walker | 18.2% |
| 57 | Vipoma | 18.2% |
| 58 | Abdominal Neoplasms | 18.2% |
| 59 | Head and Neck Neoplasms | 18.2% |
| 60 | Soft Tissue Neoplasms | 18.2% |
| 61 | Thoracic Neoplasms | 18.2% |
| 62 | Multiple Endocrine Neoplasia | 18.1% |
| 63 | Cervical Intraepithelial Neoplasia | 18.1% |
| 64 | Carcinoid Heart Disease | 17.9% |
| 65 | Retinoblastoma | 17.8% |
| 66 | Papilloma | 17.8% |
| 67 | Pseudomyxoma Peritonei | 17.8% |
| 68 | Papillomatosis | 17.8% |
| 69 | Adenomatosis, Pulmonary | 17.8% |
| 70 | Adenomatous Polyps | 17.8% |
| 71 | Gastrinoma | 17.4% |
| 72 | Glucagonoma | 17.4% |
| 73 | Renal Cell Carcinoma | 17.3% |
| 74 | Papillary Renal Cell Carcinoma | 17.3% |
| 75 | Basal Cell Nevus Syndrome | 17.2% |
| 76 | Trophoblastic Neoplasms | 17% |
| 77 | Leukemia, Experimental | 16.9% |
| 78 | Carcinoma, Endometrioid | 16.9% |
| 79 | Carcinoma, Ovarian Epithelial | 16.8% |
| 80 | Astrocytoma | 16.7% |
| 81 | Ependymoma | 16.7% |
| 82 | oligodendroglioma | 16.7% |
| 83 | Ganglioglioma | 16.7% |
| 84 | gliosarcoma | 16.7% |
| 85 | Anaplastic astrocytoma | 16.7% |
| 86 | Anaplastic Oligodendroglioma | 16.7% |
| 87 | Composite Lymphoma | 16.7% |
| 88 | Sebaceous Gland Neoplasms | 16.6% |
| 89 | Melanoma, Experimental | 16.4% |
| 90 | Lymphoma | 16.3% |
| 91 | Hepatocellular Adenoma | 16.3% |
| 92 | Carcinoma | 16.3% |
| 93 | Epithelioma | 16.3% |
| 94 | Dermoid Cyst | 15.9% |
| 95 | Leukemia, Plasma Cell | 15.8% |
| 96 | Paraneoplastic Encephalomyelitis | 15.8% |
| 97 | Cyst | 15.7% |
| 98 | Digestive System Neoplasms | 15.7% |
| 99 | Endocrine Gland Neoplasms | 15.7% |
| 100 | Eye Neoplasms | 15.7% |
| 101 | Neoplastic Processes | 15.7% |
| 102 | Neoplastic Syndromes, Hereditary | 15.7% |
| 103 | Nervous System Neoplasms | 15.7% |
| 104 | Pregnancy Complications, Neoplastic | 15.7% |
| 105 | Mammary Neoplasms, Experimental | 15.5% |
| 106 | Neoplasms, Experimental | 15.5% |
| 107 | Thymoma | 15.4% |
| 108 | Bone neoplasms | 15.3% |
| 109 | Hematologic Neoplasms | 15.3% |
| 110 | Splenic Neoplasms | 15.2% |
| 111 | Leukemia, Radiation-Induced | 15% |
| 112 | Parathyroid Neoplasms | 14.6% |
| 113 | Peritoneal Neoplasms | 14.6% |
| 114 | Thyroid Neoplasm | 14.6% |
| 115 | Thyroid carcinoma | 14.6% |
| 116 | Chondrosarcoma | 14.6% |
| 117 | Craniopharyngioma | 14.6% |
| 118 | leiomyosarcoma | 14.6% |
| 119 | liposarcoma | 14.6% |
| 120 | synovial sarcoma | 14.6% |
| 121 | Neuroectodermal Tumor, Melanotic | 14.6% |
| 122 | Angiomyolipoma | 14.6% |
| 123 | Clear Cell Sarcoma of Soft Tissue | 14.6% |
| 124 | Alveolar Soft Part Sarcoma | 14.6% |
| 125 | Neuroendocrine Tumors | 14.6% |
| 126 | Sarcoma, Myeloid | 14.6% |
| 127 | Prolactinoma | 14.4% |
| 128 | Growth Hormone-Secreting Pituitary Adenoma | 14.4% |
| 129 | Xeroderma Pigmentosum | 14.2% |
| 130 | Glioblastoma | 14.2% |
| 131 | Neuroblastoma | 14.2% |
| 132 | Glioblastoma Multiforme | 14.2% |
| 133 | Nasopharyngeal carcinoma | 14.1% |
| 134 | Neurilemmoma | 13.8% |
| 135 | Hutchinson's Melanotic Freckle | 13.8% |
| 136 | Melanoma, Amelanotic | 13.8% |
| 137 | Gynecomastia | 13.7% |
| 138 | Sarcoma, Experimental | 13.6% |
| 139 | Actinic keratosis | 13.5% |
| 140 | Mastocytosis | 13.4% |
| 141 | Ameloblastoma | 13.4% |
| 142 | Angiokeratoma | 13.4% |
| 143 | Chordoma | 13.4% |
| 144 | Hemangioma | 13.4% |
| 145 | hemangiopericytoma | 13.4% |
| 146 | Lymphangioma | 13.4% |
| 147 | Mesenchymoma | 13.4% |
| 148 | Nevus | 13.4% |
| 149 | Teratoma | 13.4% |
| 150 | Hepatoblastoma | 13.4% |
| 151 | Mixed Tumor, Mullerian | 13.4% |
| 152 | Germinoma | 13.4% |
| 153 | Teratocarcinoma | 13.4% |
| 154 | Angiofibroma | 13.4% |
| 155 | Sarcoma | 13.4% |
| 156 | Neoplasms, Radiation-Induced | 13.3% |
| 157 | Pancreatic Neoplasm | 13.1% |
| 158 | Carcinoma, Lobular | 13% |
| 159 | Ganglioneuroblastoma | 12.9% |
| 160 | insulinoma | 12.9% |
| 161 | Optic Nerve Glioma | 12.7% |
| 162 | Pyoderma Gangrenosum | 12.6% |
| 163 | Fibrosarcoma | 12.6% |
| 164 | Osteosarcoma | 12.6% |
| 165 | Nephroblastoma | 12.5% |
| 166 | Tracheal Neoplasms | 12.5% |
| 167 | Leukemia L1210 | 12.5% |
| 168 | Leukemia P388 | 12.5% |
| 169 | Endometrial Stromal Sarcoma | 12.3% |
| 170 | Tuberous Sclerosis | 12% |
| 171 | Acoustic Neuroma | 11.8% |
| 172 | Malignant Fibrous Histiocytoma | 11.7% |
| 173 | Lactation Disorder | 11.4% |
| 174 | Mastitis | 11.4% |
| 175 | Multiple Endocrine Neoplasia Type 1 | 11.4% |
| 176 | Retroperitoneal Neoplasms | 11.4% |
| 177 | Plasmacytoma | 11.2% |
| 178 | Lupus Erythematosus, Cutaneous | 11.1% |
| 179 | Panniculitis | 11.1% |
| 180 | Systemic Scleroderma | 11.1% |
| 181 | Morphea | 11.1% |
| 182 | Malignant histiocytosis | 11.1% |
| 183 | Histiocytic sarcoma | 11.1% |
| 184 | Adenomatous Polyposis Coli | 11% |
| 185 | Adenocarcinoma | 11% |
| 186 | Esophageal Neoplasms | 10.9% |
| 187 | Lymphangioleiomyomatosis | 10.9% |
| 188 | Urticaria Pigmentosa | 10.8% |
| 189 | Paraganglioma | 10.7% |
| 190 | Rhabdomyosarcoma | 10.7% |
| 191 | Giant Cell Tumor of Bone | 10.7% |
| 192 | Sarcoma 180 | 10.5% |
| 193 | Lymphomatoid Granulomatosis | 10.3% |
| 194 | Mastocytoma | 10.3% |
| 195 | Liver Neoplasms, Experimental | 10.2% |
| 196 | Erythroplasia | 10.2% |
| 197 | Follicular cyst | 10.2% |
| 198 | Mucocele | 10.2% |
| 199 | Pilonidal Cyst | 10.2% |
| 200 | Thyroglossal Cyst | 10.2% |
| 201 | Synovial Cyst | 10.2% |
| 202 | Aberrant Crypt Foci | 10.2% |
| 203 | Myxoid cyst | 10.2% |
| 204 | Thyroid Nodule | 10.2% |
| 205 | Neurofibrosarcoma | 10% |
| 206 | Testicular Neoplasms | 9.9% |
| 207 | Dermatitis | 9.9% |
| 208 | Exanthema | 9.9% |
| 209 | Facial Dermatoses | 9.9% |
| 210 | Hair Diseases | 9.9% |
| 211 | Hand Dermatoses | 9.9% |
| 212 | keratoacanthoma | 9.9% |
| 213 | Keratosis | 9.9% |
| 214 | Nail Diseases | 9.9% |
| 215 | Photosensitivity Disorders | 9.9% |
| 216 | Prurigo | 9.9% |
| 217 | Pyoderma | 9.9% |
| 218 | Rosacea | 9.9% |
| 219 | Sebaceous Gland Diseases | 9.9% |
| 220 | Skin Diseases, Vesiculobullous | 9.9% |
| 221 | Skin Ulcer | 9.9% |
| 222 | Sweat Gland Diseases | 9.9% |
| 223 | Skin Diseases, Papulosquamous | 9.9% |
| 224 | Skin Diseases, Vascular | 9.9% |
| 225 | Acneiform Eruptions | 9.9% |
| 226 | Ocular Rosacea | 9.9% |
| 227 | Subcorneal pustular dermatosis | 9.9% |
| 228 | Erythematotelangiectatic Rosacea | 9.9% |
| 229 | Papulopustular Rosacea | 9.9% |
| 230 | Chronic Actinic Dermatitis | 9.9% |
| 231 | Dermatitis, Atopic | 9.9% |
| 232 | Epidermolysis Bullosa | 9.9% |
| 233 | Mesoblastic Nephroma | 9.8% |
| 234 | Acne Vulgaris | 9.8% |
| 235 | Contact Dermatitis | 9.8% |
| 236 | Eczema | 9.8% |
| 237 | Erythema Multiforme | 9.8% |
| 238 | Intertrigo | 9.8% |
| 239 | Neurodermatitis | 9.8% |
| 240 | Rhinophyma | 9.8% |
| 241 | Perioral Dermatitis | 9.8% |
| 242 | Acne | 9.8% |
| 243 | Dermatofibrosarcoma | 9.8% |
| 244 | Dermatofibrosarcoma Protuberans | 9.8% |
| 245 | Mouth Neoplasms | 9.6% |
| 246 | Central Nervous System Neoplasms | 9.6% |
| 247 | Vascular Neoplasms | 9.6% |
| 248 | Thymus Neoplasms | 9.6% |
| 249 | Genital Neoplasms, Female | 9.5% |
| 250 | Hodgkin Disease | 9.5% |
| 251 | Lymphoma, Non-Hodgkin | 9.5% |
| 252 | Leukoplakia, Oral | 9% |
| 253 | Paraneoplastic Cerebellar Degeneration | 9% |
| 254 | Pheochromocytoma | 8.8% |
| 255 | Alveolar rhabdomyosarcoma | 8.8% |
| 256 | Phyllodes Tumor | 8.7% |
| 257 | Dysgerminoma | 8.7% |
| 258 | Hemangioendothelioma | 8.7% |
| 259 | Lipoma | 8.7% |
| 260 | Myoma | 8.7% |
| 261 | Myxoma | 8.7% |
| 262 | Neuroma | 8.7% |
| 263 | Seminoma | 8.7% |
| 264 | Angiolipoma | 8.7% |
| 265 | Myelolipoma | 8.7% |
| 266 | Neoplasms, Bone Tissue | 8.7% |
| 267 | Neoplasms, Fibrous Tissue | 8.7% |
| 268 | Smooth Muscle Tumor | 8.7% |
| 269 | Desmoplastic Small Round Cell Tumor | 8.7% |
| 270 | Chondroma | 8.7% |
| 271 | Enchondroma | 8.7% |
| 272 | Leukoplakia | 8.6% |
| 273 | Lymphocele | 8.6% |
| 274 | Pancreatic Cyst | 8.6% |
| 275 | Foot Diseases | 8.5% |
| 276 | Barrett Esophagus | 8.5% |
| 277 | Mediastinal Cyst | 8.5% |
| 278 | Neoplasm Invasiveness | 8.5% |
| 279 | Neoplasm Metastasis | 8.5% |
| 280 | Neoplasm Recurrence, Local | 8.5% |
| 281 | Parovarian Cyst | 8.5% |
| 282 | Pericardial Cyst | 8.5% |
| 283 | Thymic Cyst | 8.5% |
| 284 | Carcinogenesis | 8.5% |
| 285 | Metastasis | 8.5% |
| 286 | Dermatitis Herpetiformis | 8.5% |
| 287 | Acrodermatitis | 8.4% |
| 288 | Porokeratosis | 8.4% |
| 289 | Gianotti-Crosti Syndrome | 8.4% |
| 290 | Keratoderma, Palmoplantar | 8.4% |
| 291 | granulosa cell tumor | 8.4% |
| 292 | Primary amyloidosis | 8.4% |
| 293 | Leydig Cell Tumor | 8.4% |
| 294 | Skin Abnormalities | 8.4% |
| 295 | Skin Diseases, Infectious | 8.4% |
| 296 | Pigmentation Disorders | 8.4% |
| 297 | Adrenal Gland Neoplasms | 8.4% |
| 298 | Gastrointestinal Neoplasms | 8.4% |
| 299 | Genital Neoplasms, Male | 8.4% |
| 300 | Liver neoplasms | 8.4% |
| 301 | Uveal Neoplasms | 8.4% |
| 302 | Dermatitis, Phototoxic | 8.3% |
| 303 | Pityriasis Lichenoides et Varioliformis Acuta | 8.3% |
| 304 | Pityriasis Lichenoides | 8.3% |
| 305 | Phototoxicity | 8.3% |
| 306 | Urologic Neoplasms | 8.3% |
| 307 | Dermatomyositis | 8.3% |
| 308 | Lipomatosis | 8.3% |
| 309 | Pruritus | 8.3% |
| 310 | Erythema | 8.3% |
| 311 | Necrolytic Migratory Erythema | 8.3% |
| 312 | Cutaneous Fistula | 8.3% |
| 313 | Nephrogenic Fibrosing Dermopathy | 8.3% |
| 314 | Nephrogenic Systemic Fibrosis | 8.3% |
| 315 | Spinal Neoplasms | 8.2% |
| 316 | Bone Marrow Neoplasms | 8.2% |
| 317 | Necrobiosis Lipoidica Diabeticorum | 8.2% |
| 318 | Panniculitis, Lupus Erythematosus | 8.1% |
| 319 | Foot Ulcer | 8.1% |
| 320 | Limbic Encephalitis | 8% |
| 321 | Peutz-Jeghers Syndrome | 7.9% |
| 322 | Nose Neoplasms | 7.6% |
| 323 | Hydatidiform Mole | 7.6% |
| 324 | Galactorrhea | 7.5% |
| 325 | Erythema Induratum | 7.5% |
| 326 | Xeroderma | 7.5% |
| 327 | Palatal Neoplasms | 7.3% |
| 328 | Leukemia, Myelomonocytic, Chronic | 7.3% |
| 329 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.3% |
| 330 | Corpus Luteum Cyst | 7.3% |
| 331 | Ovarian Cysts | 7.3% |
| 332 | Lambert-Eaton Myasthenic Syndrome | 7.3% |
| 333 | Dermatitis, Photoallergic | 7.3% |
| 334 | Pituitary Adenoma | 7% |
| 335 | Pituitary Neoplasms | 7% |
| 336 | Pseudoxanthoma Elasticum | 6.9% |
| 337 | Meningeal Neoplasms | 6.8% |
| 338 | Waldenstrom Macroglobulinemia | 6.7% |
| 339 | Multiple Myeloma | 6.7% |
| 340 | Cutis Laxa | 6.6% |
| 341 | Opsoclonus-Myoclonus Syndrome | 6.6% |
| 342 | Ectodermal Dysplasia | 6.6% |
| 343 | Aplasia Cutis Congenita | 6.6% |
| 344 | Lupus Erythematosus, Discoid | 6.5% |
| 345 | Scleroderma, Limited | 6.5% |
| 346 | Choledochal Cyst | 6.5% |
| 347 | Dermatitis, Irritant | 6.5% |
| 348 | Acne Conglobata | 6.5% |
| 349 | fibroma | 6.5% |
| 350 | Fibromatosis | 6.5% |
| 351 | Osteoblastoma | 6.5% |
| 352 | Osteoma | 6.5% |
| 353 | Rhabdomyoma | 6.5% |
| 354 | Chondromatosis | 6.5% |
| 355 | Hemangioblastoma | 6.5% |
| 356 | Lymphoma, Extranodal NK-T-Cell | 6.5% |
| 357 | ovarian neoplasm | 6.4% |
| 358 | Denys-Drash Syndrome | 6.4% |
| 359 | Sturge-Weber Syndrome | 6.4% |
| 360 | Gastrointestinal Stromal Tumors | 6.3% |
| 361 | Hemangioma, Cavernous | 6.3% |
| 362 | Leukemia, T-Cell | 6.2% |
| 363 | Leukemia, B-Cell | 6.2% |
| 364 | neurofibroma | 6.2% |
| 365 | Dupuytren Contracture | 6.2% |
| 366 | Lymphoma, Follicular | 6.2% |
| 367 | T-Cell Lymphoma | 6.2% |
| 368 | Mantle cell lymphoma | 6.2% |
| 369 | Erythema Infectiosum | 6.2% |
| 370 | Exanthema Subitum | 6.2% |
| 371 | Connective Tissue Diseases | 6.1% |
| 372 | Erythema Nodosum | 6.1% |
| 373 | Myelitis, Transverse | 6% |
| 374 | Ear Neoplasms | 5.9% |
| 375 | Eyelid Neoplasms | 5.9% |
| 376 | Lung Neoplasms | 5.9% |
| 377 | Pleural Neoplasms | 5.9% |
| 378 | Anhidrosis | 5.9% |
| 379 | Cholesteatoma | 5.9% |
| 380 | Pressure Ulcer | 5.9% |
| 381 | Folliculitis | 5.9% |
| 382 | Foot Dermatoses | 5.9% |
| 383 | Hypertrichosis | 5.9% |
| 384 | Hypohidrosis | 5.9% |
| 385 | Hypotrichosis | 5.9% |
| 386 | Leg Ulcer | 5.9% |
| 387 | Miliaria | 5.9% |
| 388 | Parakeratosis | 5.9% |
| 389 | Parapsoriasis | 5.9% |
| 390 | Pityriasis | 5.9% |
| 391 | Psoriasis | 5.9% |
| 392 | Sweet Syndrome | 5.9% |
| 393 | Hidradenitis | 5.9% |
| 394 | Onycholysis | 5.9% |
| 395 | Miliaria Rubra | 5.9% |
| 396 | Hyperpigmentation | 5.9% |
| 397 | Lichenoid Eruptions | 5.9% |
| 398 | Chloracne | 5.9% |
| 399 | Toxic Epidermal Necrolysis | 5.8% |
| 400 | Stevens-Johnson Syndrome | 5.8% |
| 401 | Brain Neoplasms | 5.8% |
| 402 | Salivary Gland Neoplasms | 5.8% |
| 403 | Spinal Cord Neoplasms | 5.8% |
| 404 | Tongue Neoplasms | 5.8% |
| 405 | Uterine Neoplasms | 5.8% |
| 406 | Vaginal Neoplasms | 5.8% |
| 407 | Vulvar Neoplasms | 5.8% |
| 408 | Uterine Cancer | 5.8% |
| 409 | Fallopian Tube Neoplasms | 5.8% |
| 410 | Dermatitis, Occupational | 5.7% |
| 411 | Dermatitis, Allergic Contact | 5.6% |
| 412 | Papillon-Lefevre Disease | 5.5% |
| 413 | Tinea Capitis | 5.5% |
| 414 | Onychomycosis | 5.5% |
| 415 | Ecthyma | 5.4% |
| 416 | Meningeal Carcinomatosis | 5.4% |
| 417 | Mastocytosis, Systemic | 5.4% |
| 418 | Leukemia, Myeloid, Chronic-Phase | 5.4% |
| 419 | Fibromatosis, Aggressive | 5.3% |
| 420 | Fibromatosis, Abdominal | 5.3% |
| 421 | Ichthyosis, X-Linked | 5.3% |
| 422 | Sjogren-Larsson Syndrome | 5.2% |
| 423 | Pharyngeal Neoplasms | 5.2% |
| 424 | Pancreatic Pseudocyst | 5.2% |
| 425 | Central Nervous System Cysts | 5.2% |
| 426 | Lymphatic Metastasis | 5.1% |
| 427 | Neoplasms, Unknown Primary | 5.1% |
| 428 | Leukemic Infiltration | 5.1% |
| 429 | Neoplasm Micrometastasis | 5.1% |
| 430 | Granuloma Annulare | 5.1% |
| 431 | Bile Duct Neoplasms | 5.1% |
| 432 | gallbladder neoplasm | 5.1% |
| 433 | Intestinal Neoplasms | 5.1% |
| 434 | Penile Neoplasms | 5.1% |
| 435 | Prostatic Neoplasms | 5.1% |
| 436 | Stomach Neoplasms | 5.1% |
| 437 | Polycythemia Vera | 5.1% |
| 438 | Acantholysis | 5% |
| 439 | Pemphigoid, Benign Mucous Membrane | 5% |
| 440 | Pemphigus | 5% |
| 441 | Piedra | 5% |
| 442 | Sunburn | 5% |
| 443 | Behcet Syndrome | 4.9% |
| 444 | Argyria | 4.9% |
| 445 | Hirsutism | 4.9% |
| 446 | Urticaria | 4.9% |
| 447 | Adiposis Dolorosa | 4.9% |
| 448 | Pruritus Vulvae | 4.9% |
| 449 | Pruritus Ani | 4.9% |
| 450 | Diaper Rash | 4.8% |
| 451 | Hyperkeratosis, Epidermolytic | 4.8% |
| 452 | Bronchial Neoplasms | 4.7% |
| 453 | Laryngeal neoplasm | 4.7% |
| 454 | Multiple Pulmonary Nodules | 4.7% |
| 455 | Supratentorial Neoplasms | 4.6% |
| 456 | Endometrial Neoplasms | 4.6% |
| 457 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4.6% |
| 458 | Leukemia, Large Granular Lymphocytic | 4.6% |
| 459 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4.6% |
| 460 | Lymphoma, T-Cell, Cutaneous | 4.6% |
| 461 | Lymphoma, AIDS-Related | 4.6% |
| 462 | Enteropathy-Associated T-Cell Lymphoma | 4.6% |
| 463 | Primary Effusion Lymphoma | 4.6% |
| 464 | Bladder Neoplasm | 4.5% |
| 465 | Kidney Neoplasm | 4.5% |
| 466 | Ureteral Neoplasms | 4.5% |
| 467 | Urethral Neoplasms | 4.5% |
| 468 | Albinism | 4.5% |
| 469 | Erythema Chronicum Migrans | 4.4% |
| 470 | Polycystic Ovary Syndrome | 4.4% |
| 471 | Hidradenitis Suppurativa | 4.3% |
| 472 | Dermatomycoses | 4.3% |
| 473 | Mucocutaneous Lymph Node Syndrome | 4.3% |
| 474 | Skin Diseases, Bacterial | 4.3% |
| 475 | Drug Eruptions | 4.2% |
| 476 | Lipodystrophy | 4.2% |
| 477 | Livedo Reticularis | 4.2% |
| 478 | Malignant Atrophic Papulosis | 4.2% |
| 479 | Polyarteritis Nodosa | 4.2% |
| 480 | Takayasu Arteritis | 4.2% |
| 481 | Hypopharyngeal Neoplasms | 4.1% |
| 482 | Pleural Effusion, Malignant | 4.1% |
| 483 | Hypopharyngeal Cancer | 4.1% |
| 484 | Parotid Neoplasms | 4% |
| 485 | Prostatic Neoplasms, Castration-Resistant | 4% |
| 486 | Nelson Syndrome | 4% |
| 487 | Brain Stem Neoplasms | 4% |
| 488 | Neoplasms, Glandular and Epithelial | 4% |
| 489 | Lichen Planus | 3.9% |
| 490 | Melanosis | 3.9% |
| 491 | Chloasma | 3.9% |
| 492 | Pityriasis Rosea | 3.9% |
| 493 | Pityriasis Rubra Pilaris | 3.9% |
| 494 | Vitiligo | 3.9% |
| 495 | Lichen Nitidus | 3.9% |
| 496 | Mycosis Fungoides | 3.8% |
| 497 | Lymphomatoid Papulosis | 3.8% |
| 498 | Plasmablastic lymphoma | 3.8% |
| 499 | Nail-Patella Syndrome | 3.8% |
| 500 | Tinea Pedis | 3.8% |
| 501 | Porphyrias, Hepatic | 3.7% |
| 502 | Choroid Plexus Papilloma | 3.7% |
| 503 | Cecal Neoplasms | 3.6% |
| 504 | Duodenal Neoplasms | 3.6% |
| 505 | Burkitt Lymphoma | 3.6% |
| 506 | Mycetoma | 3.5% |
| 507 | Tonsillar Neoplasms | 3.5% |
| 508 | Cerebellar Neoplasms | 3.5% |
| 509 | Collagen Diseases | 3.3% |
| 510 | Mixed Connective Tissue Disease | 3.3% |
| 511 | Mucinoses | 3.3% |
| 512 | Alopecia | 3.3% |
| 513 | Sweating, Gustatory | 3.3% |
| 514 | Androgenetic Alopecia | 3.3% |
| 515 | Auriculotemporal Syndrome | 3.3% |
| 516 | Nasopharyngeal Neoplasms | 3.3% |
| 517 | Lice Infestations | 3.3% |
| 518 | Varicose Ulcer | 3.3% |
| 519 | Colorectal Neoplasms | 3.2% |
| 520 | Appendiceal Neoplasms | 3.1% |
| 521 | Colonic Neoplasms | 3.1% |
| 522 | Rectal Neoplasms | 3.1% |
| 523 | Cell Transformation, Viral | 3% |
| 524 | Paranasal Sinus Neoplasms | 3% |
| 525 | Sezary Syndrome | 3% |
| 526 | Acanthosis Nigricans | 2.9% |
| 527 | Alopecia Areata | 2.9% |
| 528 | Lentigo | 2.9% |
| 529 | Cartilage Diseases | 2.8% |
| 530 | Rheumatism | 2.8% |
| 531 | Chondromalacia | 2.8% |
| 532 | Zollinger-Ellison syndrome | 2.8% |
| 533 | Larva Migrans | 2.8% |
| 534 | Leishmaniasis | 2.8% |
| 535 | Molluscum Contagiosum | 2.8% |
| 536 | Angioedema | 2.8% |
| 537 | Onchocerciasis | 2.8% |
| 538 | Lupus Erythematosus, Systemic | 2.8% |
| 539 | Overlap syndrome | 2.8% |
| 540 | Chromoblastomycosis | 2.8% |
| 541 | Dermatophytosis | 2.8% |
| 542 | Sporotrichosis | 2.8% |
| 543 | Tinea | 2.8% |
| 544 | Tinea Versicolor | 2.8% |
| 545 | Trichophytosis | 2.8% |
| 546 | Hyalohyphomycosis | 2.8% |
| 547 | Acute Generalized Exanthematous Pustulosis | 2.8% |
| 548 | Giant Cell Arteritis | 2.7% |
| 549 | Temporal Arteritis | 2.7% |
| 550 | CREST Syndrome | 2.6% |
| 551 | Anus Neoplasms | 2.6% |
| 552 | Sigmoid Neoplasms | 2.6% |
| 553 | Maxillary Sinus Neoplasms | 2.6% |
| 554 | Warts | 2.5% |
| 555 | Lichen Planus, Oral | 2.5% |
| 556 | Candidiasis, Chronic Mucocutaneous | 2.4% |
| 557 | Cutaneous Candidiasis | 2.4% |
| 558 | Erysipelas | 2.4% |
| 559 | Serum Sickness | 2.4% |
| 560 | Staphylococcal Skin Infections | 2.4% |
| 561 | Variegate Porphyria | 2.4% |
| 562 | Acute intermittent porphyria | 2.4% |
| 563 | Porphyria Cutanea Tarda | 2.4% |
| 564 | Erythrasma | 2.4% |
| 565 | Arthritis, Psoriatic | 2.4% |
| 566 | Leishmaniasis, Cutaneous | 2.1% |
| 567 | Eczema Herpeticum | 2.1% |
| 568 | Menkes Kinky Hair Syndrome | 2.1% |
| 569 | Fusariosis | 2.1% |
| 570 | Cellulitis | 2.1% |
| 571 | Blastomycosis | 2% |
| 572 | Scleromyxedema | 2% |
| 573 | HIV-Associated Lipodystrophy Syndrome | 1.9% |
| 574 | Angioedemas, Hereditary | 1.8% |
| 575 | Epidermodysplasia Verruciformis | 1.8% |
| 576 | Herpes Labialis | 1.8% |
| 577 | Diabetic Foot | 1.8% |
| 578 | Rhinoscleroma | 1.8% |
| 579 | Staphylococcal Scalded Skin Syndrome | 1.8% |
| 580 | Hereditary Angioedema Type III | 1.7% |
| 581 | Hereditary Angioedema Types I and II | 1.7% |
| 582 | Mesenteric Panniculitis | 1.7% |
| 583 | Panniculitis, Peritoneal | 1.7% |
| 584 | Tietze's Syndrome | 1.7% |
| 585 | Orbital Cellulitis | 1.7% |
| 586 | Noonan Syndrome | 1.6% |
| 587 | Myxedema | 1.6% |
| 588 | Condylomata Acuminata | 1.6% |
| 589 | Furunculosis | 1.6% |
| 590 | furuncle | 1.6% |
| 591 | Impetigo | 1.6% |
| 592 | Radicular Cyst | 1.5% |
| 593 | Marfan Syndrome | 1.5% |
| 594 | carbuncle | 1.5% |
| 595 | Homocystinuria | 1.5% |
| 596 | Osteochondritis | 1.4% |
| 597 | Polymyalgia Rheumatica | 1.4% |
| 598 | Osteogenesis Imperfecta | 1.4% |
| 599 | Keloid | 1.4% |
| 600 | Rheumatoid Arthritis | 1.3% |
| 601 | Juvenile arthritis | 1.3% |
| 602 | Lupus Nephritis | 1.2% |
| 603 | Laryngomalacia | 1.1% |
| 604 | Pectus carinatum | 1.1% |
| 605 | Rheumatoid Nodule | 0.9% |
| 606 | Felty Syndrome | 0.8% |
| 607 | Bronchomalacia | 0.8% |
| 608 | Tracheomalacia | 0.8% |
| 609 | Rheumatoid Vasculitis | 0.7% |
| 610 | Mucopolysaccharidosis III | 0.7% |
| 611 | Sicca Syndrome | 0.7% |
| 612 | Sjogren's Syndrome | 0.7% |
| 613 | Lupus Vasculitis, Central Nervous System | 0.6% |
| 614 | Mucopolysaccharidosis II | 0.5% |